Last reviewed · How we verify

NCT07365969

Risk of Hysterectomy at Time of Myomectomy

Completed Last updated 30 January 2026
What this trial tests

trial in Myomectomy in 293 participants. Completed in 15 October 2025.

Timeline
15 December 2024
Primary endpoint
15 October 2025
15 October 2025

Quick facts

Lead sponsorAin Shams University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment293
Start date15 December 2024
Primary completion15 October 2025
Estimated completion15 October 2025
Sites1 location across Egypt

Conditions studied

Sponsor

Ain Shams University

Who can join

Eligibility, female only, with Myomectomy or Fibroid Uterus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Uterine fibroids are the commonest tumor affecting the female reproductive tract and many instances they are asymptomatic but in some women there does appear to be an association with heavy menstrual blood loss and possibly subfertility. Classically, treatment has been surgical with hysterectomy the most common approach for women who have completed their fertility and myomectomy for those who wish to conceive. The surgery can be carried out laparoscopically, vaginally and abdominally. The aim of this study is to evaluate the risk of hysterectomy at the time of myomectomy, and the associated 30-day postoperative morbidity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myomectomy

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07365969.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing